Lv et al. demonstrated that AS-IV could inhibit HG from inducing human tumor precursor cell (TPC) apoptosis by down-regulating TGF-β1 and inhibiting the p38MAPK pathway [9]. This evidence concerns the gene TGFB1 and neoplasm.